1. Risk: AI Monoculture (Shared Blind Spots). This is the most critical and overlooked systemic vulnerability. Building your ...

To create a script with Visual Basic Code on Windows 11 (or 10), use these steps: Click the File menu and select the "New ...

Retrieval-augmented generation breaks at scale because organizations treat it like an LLM feature rather than a platform ...

Black Belt Drills is the ultimate source for online martial arts training. Click here for your free trial: Ernie Reyes Jr.

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

A new sample of the ToneShell backdoor, typically seen in Chinese cyberespionage campaigns, has been delivered through a kernel-mode loader in attacks against government organizations.

Multiple factors contribute to a positive patient experience, says the new CMO of AdventHealth Altamonte Springs. They include effective communication with patients, the hospital environment, food ...

If 2023 was the year of shock and 2024 was the year of experimentation, 2025 marks the moment the corporate world finally accepted that artificial intelligence is not just a novelty—it is the new ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...